Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn ' s Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

Conditions: Crohn ' s Disease Interventions: Drug: Strategy A; Drug: Strategy B Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Takeda France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials